Anchor Study Websites
A New Indication, A New Era | VASCEPA® (icosapent ethyl)
Significantly reduce CV risk with unprecedented results. Official HCP Website. New indication means a new era in cardiovascular risk reduction.
2,231,922
$
480.00
Significantly reduce CV risk with unprecedented results. Official HCP Website. New indication means a new era in cardiovascular risk reduction.
2,231,922
$
480.00
